Movement Disorders Clinical Practice

1.7(top 50%)

impact factor

1.5K(top 20%)

papers

11.3K(top 20%)

citations

39(top 20%)

h-index

1.8(top 50%)

impact factor

2.1K

all documents

13.6K

doc citations

53(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide	Movement Disorders Clinical Practice	2020	168
2	Data Analytics from Enroll‐HD, a Global Clinical Research Platform for Huntington's Disease	Movement Disorders Clinical Practice	2017	137
3	The Semiology of Tics, Tourette's, and Their Associations	Movement Disorders Clinical Practice	2014	120
4	Subthalamic Nucleus Versus Globus Pallidus Internus Deep Brain Stimulation: Translating the Rematch Into Clinical Practice	Movement Disorders Clinical Practice	2014	115
5	Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort	Movement Disorders Clinical Practice	2018	115
6	Epidemiology of Parkinson's Disease—East Versus West	Movement Disorders Clinical Practice	2018	114
7	Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review	Movement Disorders Clinical Practice	2014	103
8	The Clinical Syndrome of Paroxysmal Exercise-Induced Dystonia: Diagnostic Outcomes and an Algorithm	Movement Disorders Clinical Practice	2014	100
9	The Pragmatic Treatment of Wilson's Disease	Movement Disorders Clinical Practice	2014	94
10	Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience	Movement Disorders Clinical Practice	2020	91
11	Handwriting Analysis in Parkinson's Disease: Current Status and Future Directions	Movement Disorders Clinical Practice	2017	84
12	Adult-Onset Primary Dystonic Tics: A Different Entity?	Movement Disorders Clinical Practice	2014	80
13	TikTok Tics: A Pandemic Within a Pandemic	Movement Disorders Clinical Practice	2021	80
14	Cognitive Behavioral Therapy in Movement Disorders: A Review	Movement Disorders Clinical Practice	2015	79
15	Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers	Movement Disorders Clinical Practice	2014	74
16	Management of Depression in Parkinson's Disease: A Systematic Review	Movement Disorders Clinical Practice	2017	67
17	Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories	Movement Disorders Clinical Practice	2019	67
18	Differences in MDS‐UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration	Movement Disorders Clinical Practice	2017	65
19	Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort	Movement Disorders Clinical Practice	2017	65
20	Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis	Movement Disorders Clinical Practice	2019	65
21	Tics and TikTok: Functional Tics Spread Through Social Media	Movement Disorders Clinical Practice	2021	63
22	Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension	Movement Disorders Clinical Practice	2017	62
23	Tics in the Pediatric Population: Pragmatic Management	Movement Disorders Clinical Practice	2017	61
24	Levodopa‐Induced Neuropathy: A Systematic Review	Movement Disorders Clinical Practice	2019	61
25	The New Freezing of Gait Questionnaire: Unsuitable as an Outcome in Clinical Trials?	Movement Disorders Clinical Practice	2020	57
26	Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease	Movement Disorders Clinical Practice	2017	56
27	Developing a Tool for Remote Digital Assessment of Parkinson's Disease	Movement Disorders Clinical Practice	2016	55
28	Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown	Movement Disorders Clinical Practice	2020	53
29	Resting‐state Functional MRI in Parkinsonian Syndromes	Movement Disorders Clinical Practice	2019	52
30	A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S‐FMDRS)	Movement Disorders Clinical Practice	2017	51
31	Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease	Movement Disorders Clinical Practice	2017	49
32	The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease	Movement Disorders Clinical Practice	2018	49
33	Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?	Movement Disorders Clinical Practice	2017	48
34	Challenges in PD Patient Management After DBS: A Pragmatic Review	Movement Disorders Clinical Practice	2018	48
35	Official Japanese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale: Validation Against the Original English Version	Movement Disorders Clinical Practice	2014	47
36	Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology	Movement Disorders Clinical Practice	2015	47
37	Frequency of GBA Variants in Autopsy‐proven Multiple System Atrophy	Movement Disorders Clinical Practice	2017	47
38	Physical Activity, Exercise, and Physiotherapy in Parkinson's Disease: Defining the Concepts	Movement Disorders Clinical Practice	2020	47
39	Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations	Movement Disorders Clinical Practice	2016	46
40	Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism	Movement Disorders Clinical Practice	2018	46
41	Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor	Movement Disorders Clinical Practice	2018	46
42	Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study	Movement Disorders Clinical Practice	2020	45
43	C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature	Movement Disorders Clinical Practice	2018	44
44	Sleep Disorders in Atypical Parkinsonism	Movement Disorders Clinical Practice	2014	42
45	The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management	Movement Disorders Clinical Practice	2016	42
46	Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study	Movement Disorders Clinical Practice	2018	42
47	The Cholinergic Brain in Parkinson's Disease	Movement Disorders Clinical Practice	2021	42
48	The New Classification System for the Dystonias: Why Was It Needed and How Was It Developed?	Movement Disorders Clinical Practice	2014	41
49	Myoclonus and Cerebellar Ataxia Following COVID‐19	Movement Disorders Clinical Practice	2020	41
50	The Phenomenology of Functional (Psychogenic) Dystonia	Movement Disorders Clinical Practice	2014	40

Scientometrics

Overviews

Citing Bodies

Movement Disorders Clinical Practice

Top Articles